Heat-activated thermosensitive liposomal cisplatin (HTLC) results in effective growth delay of cervical carcinoma in mice
Cisplatin (CDDP) has been identified as the primary chemotherapeutic agent for the
treatment of cervical cancer, but dose limiting toxicity is a key issue associated with its …
treatment of cervical cancer, but dose limiting toxicity is a key issue associated with its …
Heat-activated thermosensitive liposomal cisplatin (HTLC) results in effective growth delay of cervical carcinoma in mice
YN Dou, J Zheng, WD Foltz… - … : official journal of …, 2014 - pubmed.ncbi.nlm.nih.gov
Cisplatin (CDDP) has been identified as the primary chemotherapeutic agent for the
treatment of cervical cancer, but dose limiting toxicity is a key issue associated with its …
treatment of cervical cancer, but dose limiting toxicity is a key issue associated with its …
Heat-Activated Thermosensitive Liposomal Cisplatin (HTLC) Results in Effective Growth Delay of Cervical Carcinoma in Mice
YN Dou, J Zheng, WD Foltz, R Weersink… - … of Cisplatin for …, 2017 - search.proquest.com
Cisplatin (CDDP) is currently a leading chemotherapeutic agent that is approved for
treatment of lung, ovarian, head and neck, bladder, testicular and cervical cancers (1) …
treatment of lung, ovarian, head and neck, bladder, testicular and cervical cancers (1) …
[PDF][PDF] Heat-Activated Thermosensitive Liposomal Cisplatin (HTLC) Results in Effective Growth Delay of Cervical Carcinoma in Mice
YN Dou, J Zheng, WD Foltz… - … of Cisplatin for …, 2017 - dam-oclc.bac-lac.gc.ca
Cisplatin (CDDP) is currently a leading chemotherapeutic agent that is approved for
treatment of lung, ovarian, head and neck, bladder, testicular and cervical cancers (1) …
treatment of lung, ovarian, head and neck, bladder, testicular and cervical cancers (1) …
[PDF][PDF] Heat-Activated Thermosensitive Liposomal Cisplatin (HTLC) Results in Effective Growth Delay of Cervical Carcinoma in Mice
YN Dou, J Zheng, WD Foltz… - … of Cisplatin for …, 2017 - tspace.library.utoronto.ca
Cisplatin (CDDP) is currently a leading chemotherapeutic agent that is approved for
treatment of lung, ovarian, head and neck, bladder, testicular and cervical cancers (1) …
treatment of lung, ovarian, head and neck, bladder, testicular and cervical cancers (1) …
Heat-activated thermosensitive liposomal cisplatin (HTLC) results in effective growth delay of cervical carcinoma in mice
YN Dou, J Zheng, WD Foltz, R Weersink… - Journal of Controlled …, 2014 - infona.pl
Cisplatin (CDDP) has been identified as the primary chemotherapeutic agent for the
treatment of cervical cancer, but dose limiting toxicity is a key issue associated with its …
treatment of cervical cancer, but dose limiting toxicity is a key issue associated with its …
Heat-activated thermosensitive liposomal cisplatin (HTLC) results in effective growth delay of cervical carcinoma in mice.
YN Dou, J Zheng, WD Foltz, R Weersink… - Journal of Controlled …, 2014 - europepmc.org
Cisplatin (CDDP) has been identified as the primary chemotherapeutic agent for the
treatment of cervical cancer, but dose limiting toxicity is a key issue associated with its …
treatment of cervical cancer, but dose limiting toxicity is a key issue associated with its …
Heat-activated thermosensitive liposomal cisplatin (HTLC) results in effective growth delay of cervical carcinoma in mice
YN Dou, J Zheng, WD Foltz… - Journal of …, 2014 - mdanderson.elsevierpure.com
Cisplatin (CDDP) has been identified as the primary chemotherapeutic agent for the
treatment of cervical cancer, but dose limiting toxicity is a key issue associated with its …
treatment of cervical cancer, but dose limiting toxicity is a key issue associated with its …
[引用][C] Heat-activated thermosensitive liposomal cisplatin (HTLC) results in effective growth delay of cervical carcinoma in mice
YN Dou, J Zheng, WD Foltz, R Weersink… - Journal of Controlled …, 2014 - cir.nii.ac.jp
Heat-activated thermosensitive liposomal cisplatin (HTLC) results in effective growth delay
of cervical carcinoma in mice | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲ恁縖サイニィ …
of cervical carcinoma in mice | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲ恁縖サイニィ …
Heat-Activated Thermosensitive Liposomal Cisplatin (HTLC) Results in Effective Growth Delay of Cervical Carcinoma in Mice
YN Dou, J Zheng, WD Foltz, R Weersink… - … of Cisplatin for …, 2017 - search.proquest.com
Cisplatin (CDDP) is currently a leading chemotherapeutic agent that is approved for
treatment of lung, ovarian, head and neck, bladder, testicular and cervical cancers (1) …
treatment of lung, ovarian, head and neck, bladder, testicular and cervical cancers (1) …
